Loading
Loading
Review of Case Materials
Reviews records, documents, testimony, data, and other relevant materials and consults with counsel regarding technical issues related to the matter.
Provide Expert Analysis
Applies specialized knowledge and experience to evaluate the technical or professional issues involved.
Form Expert Opinions
Develops independent, supportable opinions based on the available evidence and relevant standards.
Prepare Expert Reports
Showing Results 0 of 0
The relevant evidence may include prescriptions, medication administration records, pharmacy records, dose histories, laboratory and toxicology findings, prescribing information, product labels, adverse-event documentation, medical records, research data, and regulatory materials. The records selected should follow the particular drug question rather than assuming every medication dispute requires the same analysis. FDA prescription labeling, for example, separately addresses dosage and administration, warnings and precautions, adverse reactions, and clinically significant drug interactions.
An interaction analysis can begin with the complete medication and substance history, doses, timing, route of administration, relevant laboratory results, prescribing information, and the chronology of the claimed effect. The expert can then assess whether a recognized interaction is relevant to the drugs and circumstances actually involved and whether the medical evidence is consistent with that mechanism. FDA notes that one form of drug-drug interaction occurs when a co-administered drug changes another drug's concentration, potentially altering effectiveness or adverse-effect risk.
Research evidence may include preclinical studies, clinical-trial protocols, study reports, safety data, dose information, statistical analyses, and documents concerning how a drug was investigated. The relevance of those materials depends on the question being disputed and the population, dose, indication, and outcome studied. FDA's drug-development framework progresses from discovery and preclinical research through clinical research, regulatory review, and post-market safety monitoring. Clinical trials use protocols defining matters such as participant selection, dosage, assessments, and data collection.
Regulatory records may matter when a dispute involves labeling, approval history, safety information, post-market developments, or the evidence submitted concerning a drug. An expert can explain the scientific or regulatory record relevant to the product while leaving ultimate legal conclusions to counsel and the applicable decision-maker. For new drugs, FDA review can include nonclinical and clinical data, proposed labeling, manufacturing information, and analyses concerning safety and effectiveness.
Prepares clear, well-supported expert reports outlining methodology, analysis, findings, and opinions.
Provide Deposition Testimony
Explains findings and opinions under oath and responds to questioning during deposition testimony.
Testify in Court
Presents specialized findings and opinions clearly to judges, juries, arbitrators, or other decision-makers.
The principal issue should control expert selection. A dispute centered on drug mechanisms or pharmacokinetics may fit Pharmacology; poisoning or overdose may require Medical Toxicology; and pharmacy practice may call for Pharmacy. Opioid- or narcotic-related matters may require expertise matched to the particular substance and disputed question. Fentanyl-overdose matters, for example, may require toxicology, pharmacology, pathology, or other specialized expertise depending on whether the issue concerns exposure, drug effects, clinical treatment, or cause of death. Likewise, pesticide poisoning is better treated through pesticide or toxicology expertise when the pesticide exposure itself is central. EPA evaluates pesticide health risks through hazard identification, dose-response assessment, exposure assessment, and risk characterization, illustrating why pesticide poisoning presents a more specialized toxicological question.
